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Background: Copy number variants (CNVs) have been shown to play an important role in genetic diversity of
mammals and in the development of many complex phenotypic traits. The aim of this study was to perform a
standard comparative evaluation of CNVs in horses using three different CNV detection programs and to identify
genomic regions associated with body size in horses.
Results: Analysis was performed using the Illumina Equine SNP50 genotyping beadchip for 854 horses. CNVs were
detected by three different algorithms, CNVPartition, PennCNV and QuantiSNP. Comparative analysis revealed 50
CNVs that affected 153 different genes mainly involved in sensory perception, signal transduction and cellular
components. Genome-wide association analysis for body size showed highly significant deleted regions on ECA1,
ECA8 and ECA9. Homologous regions to the detected CNVs on ECA1 and ECA9 have also been shown to be
correlated with human height.
Conclusions: Comparative analysis of CNV detection algorithms was useful to increase the specificity of CNV
detection but had certain limitations dependent on the detection tool. GWAS revealed genome-wide associated
CNVs for body size in horses.
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The determination of copy number variants (CNVs) has
become increasingly important for the evaluation of gen-
omic traits in domestic animals [1]. CNVs have been
shown to be a major source for genetic variation es-
pecially in complex traits influencing gene expression,
phenotypic variation, adaption and the development
of diseases [2,3]. Analyses using different detection
methods have been performed in diverse species like
cows, pigs and horses [4-7]. Recent whole-genome se-
quencing revealed 282 CNVs in a quarter horse mare
and suggested CNVs to be an important resource for
future studies of complex diseases and traits in horses
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reproduction in any medium, provided the orarray comparative genomic hybridization (CGH) method-
ology and the CNV detection algorithm PennCNV
using whole genome SNP genotyping chips [4,5]. Both
techniques have been shown to be a valid method to
detect CNVs [3,6,9]. It was proposed that a compari-
son between these methods might be an important
step for understanding the advantages and disadvan-
tages of these platforms [9]. SNP arrays were proposed to
be advantageous due to lower prices, lower signal-to-
noise ratios and the use of the parameter B-allele fre-
quency which facilitates the interpretation of results
[1,6,10]. Furthermore, less samples per experiment
were assumed to be required for SNP genotyping
compared to CGH analyses [11]. However, the main
bias for SNP arrays was considered to be the low
SNP coverage of the genome in regions of CNVs due
to difficulties of assay development and implementa-
tion [11]. In CGH arrays the genome coverage wasl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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In pig breeds CGH analyses have been proposed to
be advantageous due to an enhanced marker density
and a uniform distribution of probes [12]. CNV ana-
lyses in horses were performed on a CGH array
which only targeted exons and therefore did not
allow an identification of CNVs in intergenic regions
[5]. This was taken into account for the benefit of
detecting smaller CNVs in coding exons of anno-
tated genes [5].
CNV calls in CGH as well as SNP arrays have been
considered to be highly dependent on the algorithms
used for the identification of CNVs [11,13,14]. For SNP
arrays, various CNV detection programs have been avail-
able. Comparative analyses of CNV detection algorithms
suggested that multiple predictions from different detec-
tion programs increased the confidence in the data and
helped to eliminate false positive results [11]. Neverthe-
less the accuracy of CNV detection by different algo-
rithms has also been shown to be limited due to false
negative results [15,16]. SNP array analyses in horses
have not been performed in more than one CNV detec-
tion algorithm yet [4]. On the other hand, the analysed
horse populations varied from a low number of horses
(16) of diverse breeds used in the CGH study, to a
higher number of horses (520) of a few breeds (4) in
SNP array based PennCNV detections [4,5,17]. Due to
the development of the horse population into a highly
variable group, evaluations of different breeds have
been shown to be important, especially for complex
variations which are supposed to be challenging due
to genetic heterogeneity and variations in the pheno-
typic expression [18,19].
Genome-wide association studies (GWAS) for height
have been performed for CNVs in human and revealed
copy-number variants that were proposed to play a role
in the development of short stature [20]. Recent studies
in horses identified CNVs in the region of genes mainly
involved in sensory perception, signal transduction and
metabolism but also in candidates for neuronal homeo-
stasis, coat colour, blood group antigens, keratin forma-
tion and height [5]. A quantitative trait locus (QTL) for
stature was found on equine chromosome (ECA) 16 at
75 Mb. Size variation in horses has been investigated in
various GWAS for single nucleotide polymorphisms
(SNPs) using BeadChip data [19,21-23]. On the whole, five
loci on ECA3, ECA6, ECA9, ECA11 and ECA28 have been
discussed to be probably involved in the determination of
withers height. A functional polymorphism on ECA3 was
shown to be highly associated with body size and with the
relative expression levels of the adjacent gene ligand
dependent nuclear receptor corepressor-like (LCORL) [23].
It was assumed that LCORL might be a main regulator for
the determination of body size in horses.The aim of this study was to perform CNV detection
analyses in accordance with current standards using
three CNV detection algorithms in a large number of
horses of various breeds and to compare these results
with current microarray studies. The CNVs detected
were further analysed for their association with body size
as a model for complex traits.
Results and discussion
CNV detection
The detection of CNVs was performed on the data of
the Illumina Equine SNP50 beadchip using the algorithms
CNVPartition (Illumina), PennCNV [17] and QuantiSNP
[24]. Analysis revealed 166, 860 and 1090 CNVs using
these programs for the detection (Additional file 1,
Additional file 2 and Additional file 3). The mean size
for all detected CNVs was 487,562 bp and the median
169,367 bp. Considering the distribution of CNVs
over the chromosomes, the detection results of PennCNV
revealed the largest number of CNVs on ECA1, ECA12
and ECA13 while the results of QuantiSNP showed an en-
richment of CNVs on ECA1, ECA3 and ECA12 (Figure 1).
Detection analysis by CNVPartition revealed a high
number of detected CNVs on ECA1, ECA12 and ECA23.
However, the chromosomes with the highest numbers of
CNVs did not necessarily show the highest coverage with
CNV regions. We found strong CNV coverage enrichment
on ECA23 (CNVPartition), ECA13 (PennCNV), ECA27
and ECA28 (PennCNV and QuantiSNP) and ECA12
(all three programs, Table 1). Across all three detec-
tion algorithms, ECA12 was not only significantly
enriched by CNVs but also showed the largest num-
ber of detected CNVs. An accumulation of CNVs has
also been reported in CGH analyses in horses for ECA12,
ECA17 and ECA23 and was shown in Illumina Equine
SNP50 beadchip based PennCNV analyses for ECA1,
ECA2 and ECA17 [4,5]. We assume that the amount of
detected CNVs on specific chromosomes is dependent on
the detection method and can vary among different popu-
lations. Nevertheless, there is much evidence to presume
that ECA12, ECA27 and ECA28 are considerably enriched
for CNVs.
Comparison between three detection programs
Comparative analysis between the algorithms showed
that PennCNV and QuantiSNP detected similar numbers
of CNVs identified on each autosome. They displayed a
CNV detection overlap of 28.4% and 22.8% (Figure 2).
The percentage of CNVs overlapping with CNVPartition,
the algorithm with the lowest number of detected
CNVs, was 32.5% (PennCNV) and 37.4% (QuantiSNP). In
total, 50 CNVs could be detected by all three programs
(Additional file 4). The average size of these 50 CNVs
detected by all three programs was 388,892 bp and
Figure 1 Chromosomal distribution of CNVs detected by different detection algorithms. (A) Detection results of CNVPartition. (B)
Detection results of PennCNV. (C) Detection results of QuantiSNP.
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Table 1 Chromosomal enrichment of CNVs detected by
three different algorithms
Chromosome CNVPartition (%) PennCNV (%) QuantiSNP (%)
1 2.1 4.3 18.5
2 0.6 7.6 31.0
3 0.5 3.6 29.1
4 0.8 4.7 20.7
5 0.5 4.2 18.6
6 1.8 4.2 22.0
7 0.9 6.6 19.4
8 0.5 3.9 15.1
9 1.2 4.7 15.1
10 1.3 7.1 26.3
11 2.5 4.0 25.9
12 8.6 15.7 54.7
13 1.4 91.8 36.3
14 0.3 3.6 19.9
15 0.9 4.7 10.2
16 0 2.1 10.2
17 1.7 7.7 21.3
18 1.5 5.3 14.1
19 0 3.6 3.1
20 2.3 2.7 5.2
21 0 4.4 19.1
22 0 3.0 28.6
23 26.4 2.9 15.0
24 1.0 2.5 4.9
25 3.6 6.2 22.5
26 0 3.0 11.0
27 0 79.1 90.9
28 0.4 70.7 65.4
29 1.4 1.5 8.6
30 3.6 4.3 36.8
31 0 4.1 3.9
Total coverage 1.7 9.0 22.0
The proportion of the chromosome covered by detected CNVs is shown.
Figure 2 Overlapping CNVs from the three CNV-detection
programs used in analysis. 50 CNVs could be detected by all
three algorithms.
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The number of losses and gains was computed among
those breeds that revealed a CNV in all three algorithms
(see Additional file 4). On the whole, five CNVs showed
higher copy numbers in some and lower copy numbers in
other horses while further 28 CNVs only displayed losses
and 17 CNVs only gains in these horses.
Comparisons between our detection results of the 50
CNVs detected in all three programs with recent CNV
studies [4,5] showed that these 50 CNV regions were
highly similar to those CNV regions in previous studiesespecially for SNP array analyses (Table 2). Nevertheless,
the study by Dupuis et al. revealed a considerably higher
number of detected CNVs [4]. We propose that this
effect was a result of more stringent quality criteria and
the combination of three detection algorithms used in
our study.
CGH analyses showed less concordance with our de-
tection events. It was proposed that the results of CGH
and SNP arrays were generally not easily comparable [1].
In particular, the CNV-study designs in horses were dif-
ferent, as CGH analyses only targeted exons, while the
SNP arrays covered the whole genome. Furthermore,
our analysis was performed on a considerably higher
number of samples that might allow a more general view
on the distribution of CNVs in the horse population.
Comparisons between the CNV regions detected by
CGH analyses and those identified by the three SNP
array detection algorithms individually revealed a relatively
high overlap with the detection results of QuantiSNP
(25%), less consistency with the PennCNV results (7%) and
an extremely low overlap with CNVPartition (3%, Table 3).
Despite the relatively low overlap in total, PennCNV
showed concordance up to 100% in some chromosomal
regions. These comparisons confirm the assumption that
the prediction accuracy of CNVPartition seems to be rela-
tively poor due to the high rates of missed events
[11]. We suppose that this was the reason for the
considerably high number of detected CNVs by indi-
vidual programs in comparison with the number of
overlapping detection events. A closer look at each al-
gorithm showed that PennCNV and QuantiSNP provided
a similar distribution of CNVs over the chromosomes and
Table 2 CNV regions from 50 CNVs of three detection algorithms in comparison with recent studies
ECA CNV regions detected by CNVPartition,
PennCNV, QuantiSNP (717 horses) (bp)
CN Samples (n) CNV regions detected by
PennCNV (477 horses);
Dupuis et al. (bp)
CN Samples (n) CNV regions detected
CGH analysis (16 horses);
Doan et al. (bp)
CN Samples (n)







1 178798269- 179550475 Loss, gain 10, 5 178798269-178815370 Loss 1 ─
178798269-179550475 Gain 3
2 106062109-106063373 Gain 20 106062109-106064917 Loss 7 ─
3 65705932- 65951800 Loss, gain 27, 29 65705932-66065643 Gain 50 ─
4 52424614-52612016 Gain 20 52194368-52612016 Gain 1 ─
5 37840041-37916448 Loss 16 37840041-37916448 Loss 5 37878731-37954286 Loss, gain 9, 8
5 88243192-88258862 Gain 57 88243192-88349479 Gain 27 ─
6 26086675-26126581 Gain 42 26102028-26126581 Gain 1 ─
6 72032729-72607543 Loss, gain 136, 11 71956823-72607543 Loss 71 71977669-73390784 Loss, gain 5, 1
7 31406445-31520977 Loss 17 31406445-31529855 Loss 10 ─
7 52610482-52677786 Gain 37 52610482-52677786 Gain 39 52617898-52737112 Loss, gain 5 ,4
7 73083306-73197149 Loss, gain 14, 3 73083306-73197149 Loss 3 73056824-73699458 Loss, gain 14, 14
8 4280605-4621044 Loss, gain 37, 40 4183178-4430473 Loss 2 4381193-4648028 Gain 2
9 31574454-31574969 Loss 4 ─ ─ ─ ─
10 674485-1271225 Loss, gain 1, 6 674485-1141923 Gain 10 ─
11 54645681-54812394 Loss 47 54640169-54812394 Loss 1 ─
12 12524489-14777981 Loss, gain 108, 116 12524489-13488187 Loss 32 12314908-15866355 Loss, gain 12, 13
13945011-14777981 Loss 114
18 11660478-12399073 Gain 2 ─ ─ ─ ─
20 32059082-32210308 Loss, gain 24, 3 32059082-32250493 Gain 9 32031829-32033708 Loss 1
24 32416012-32628728 Loss, gain 1, 11 32416012-32628728 Gain 20 ─
25 26318531-27125754 Loss, gain 137, 4 26318531-26942120 Loss 99 26274719-26980393 Loss, gain 2, 2




















Table 3 Comparison between 754 CNV regions detected
by CGH analyses and the SNP array detection results of
CNVPartition, PennCNV and QuantiSNP
ECA Number of CNV
regions detected
CGH analysis,













1 67 11 11 24
2 31 3 3 35
3 35 0 3 29
4 27 7 11 15
5 44 0 0 11
6 29 7 4 14
7 50 2 4 12
8 24 4 4 38
9 17 0 6 29
10 31 0 0 48
11 39 3 5 28
12 15 7 13 47
13 22 0 55 55
14 32 0 3 34
15 33 0 0 3
16 23 0 0 13
17 22 0 5 14
18 27 0 0 19
19 14 0 0 0
20 47 4 9 17
21 18 0 0 33
22 21 0 0 29
23 17 6 6 24
24 10 0 0 0
25 14 29 29 43
26 4 0 0 0
27 7 0 57 86
28 5 0 100 80
29 6 17 0 17
30 14 0 0 50
31 9 0 0 0
total 754 3 7 25
All CNV regions that show an overlap of at least 50% with the CNV region
detected by CGH are displayed for each chromosome. The highest overlap can
be seen with QuantiSNP.
Metzger et al. BMC Genomics 2013, 14:487 Page 6 of 15
http://www.biomedcentral.com/1471-2164/14/487had a considerably higher number of detection events
in comparison with CNVPartition. PennCNV and
QuantiSNP are both hidden Markov model (HMM)
based algorithms that use the log R ratio and B allele
frequency independently (QuantiSNP) or in combin-
ation (PennCNV) [25]. Comparative analyses of CNV
detection methods for SNP arrays confirmed thatPennCNV and QuantiSNP had a large overlap of detection
events [11]. A study of bladder cancer in human which
used a study design similar to ours suggested PennCNV
and QuantiSNP to be a more reliable method for the de-
tection of CNVs than CNVPartition [26]. QuantiSNP was
even assumed to be the best of these three methods and
also outperformed the other algorithms [25].
CNV sharing among breeds
After filtering out samples with low call rate and quality
features we were able to detect CNVs in 717 horses. The
total number of detected (identical and not identical)
CNVs was 4013 for these horses of different breeds. Due
to the choice of unrelated horses, we supposed this
number of CNVs gives a good view on the distribution
of CNVs in the horse population with the restriction that
different numbers of samples were available per breed.
Comparative analysis of all three algorithms revealed
536 CNVs that could be detected in all programs for
the same breed. These CNVs were found in Arabian,
Hanoverian, Holsteiner, Lusitano, Maremanno, Oldenburg,
Thoroughbred, Westphalian (Table 4). With regard to the
individuals we could confirm 21 CNVs that were detected
in the same horse using all algorithms. Theses CNVs
ranged in size from 516 to 862,853 bp and showed an aver-
age size of 368,720 bp. Further 29 CNVs showed an over-
lap among different breeds (Table 5).
Comparisons between the 50 CNVs derived from all
three detection algorithms showed that the largest num-
ber of CNVs occurred in the Hanoverians, supposably
due to the largest number of samples used in this study.
On the whole 18 Hanoverian specific CNVs could be
detected. Two of these showed gains and losses in
different horses (Additional file 4). In general, only
one CNV derived from the comparative analysis of three
detection algorithms showed losses and gains among
different breeds. This CNV was located on ECA1 at
155.49-155.55 Mb and showed losses in Hanoverian
and Lusitano and gains in Holsteiner and Thoroughbred
horses.
Furthermore a relatively high number of CNVs shared
with the Hanoverian could also be found in Oldenburg,
Westphalian and Holsteiner, presumably due to the close
relationship among these breeds. A CNV overlap be-
tween Arabian, Lusitano and Maremanno horses could
be explained by the strong influence of the Arabian and
Lusitano bloodlines on the Maremanno breed. In
addition, we investigated the distribution of CNVs in
two Przewalski horses and detected on the whole 10
CNVs which could not be identified by all three detec-
tion algorithms but showed an overlap with different
breeds (Additional file 5). We assume that these CNVs
might be conserved for a long time and passed on dur-
ing the domestication of the horse.







Number of CNVs derived




Number of CNVs derived
from the inter-section
detected in the same horse
Number of
animals (n)
Anglo-Arabian 165 1 1 0 0 0 0
Arabian 148 87 713 16 15 1 1
Brandenburger 168 1 1 0 0 0 0
Hanoverian 168 458 2508 442 262 11 10
Holsteiner 168 6 51 2 2 2 2
Lusitano 160 47 263 40 28 0 0
Maremanno 160 44 177 17 13 1 1




165 2 9 0 0 0 0
Rhinelander
horse
168 11 49 0 0 0 0
German Riding
Pony
148 1 7 0 0 0 0
Selle Francais 165 1 2 0 0 0 0
Thoroughbred 163 13 47 2 2 1 1
Trakehner 168 3 13 0 0 0 0
Westphalian 168 29 112 13 12 2 2
Zweibrücker 168 1 6 0 0 0 0
Total ─ 717 4013 536 338 21 17
The total number of CNVs, the number of CNVs derived from the 50 CNVs of all three detection programs (intersection) and the number of animals which showed
these CNVs in at least one algorithm is displayed. The last two columns show the more stringent category with the number of CNVs that were detected in the
same horse in all three algorithms and with the number of horses under these conditions.
Table 5 Number of CNVs derived from the 50 calls of all three detection algorithms that overlap among different
breeds




Hol 8 1 1
Bran 1 1 0 0
RPon 1 1 1 1 0
Trak 3 1 1 1 0 1
TB-H 4 0 2 0 0 0 1
AV 12 6 4 2 1 1 1 0
Lus 10 5 3 2 1 1 2 1 6
Mar 10 4 3 3 1 1 1 1 5 8
RDK 3 2 2 2 0 1 1 0 1 2 2
RHD 4 3 4 1 0 1 1 1 3 1 2 1
On the whole 13 breeds shared their CNV with another breed (Han Hanoverian, Lus Lusitano, Mar Maremanno, Old Oldenburg, RDK Rhenish-German Cold-Blood,
Wes Westphalian, Hol Holsteiner, TB-H Thoroughbred, AV Arabian, RHD Rhinelander horse, Bran Brandenburger, Trak Trakehner, RPon German Riding Pony).
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horses shared their CNVs with at least another animal
according to previous observations [5]. Comparing the
average size of CNVs detected in more than one animal
(397,708 bp) with the size of CNVs not shared by a sec-
ond horse (250,773 bp) confirmed the suggestion that
CNV sharing among horses is correlated with CNV
length as larger CNVs are more likely to be shared [5].
Analysis of genes within CNV regions
Analysis of genomic regions of 50 CNVs, derived from
comparative analysis of CNV detection algorithms, re-
vealed 153 different genes within 45 CNVs. In five CNV
regions we were not able to find any functional gene.
The major category of genes consisted of olfactory re-
ceptor (OR) genes (66.7%), a group of genes which is
known to be significantly enriched in CNV regions in
human, cattle, pig and rat [6,7,27,28]. It was supposed
that the overrepresentation of OR genes is not a result
of positive selection but of the frequent appearance of
these genes in segmentally duplicated regions [27].
These regions are known to be more susceptible to
CNVs while genomic regions with dosage-sensitive genes
usually show a low number of CNVs [3,27].
Functional analysis was performed using human
orthologs of the horse genes due to the poor annotation
of the horse genome. The results of the Database for
Annotation, Visualization and Integrated Discovery
(DAVID) 6.7 showed an enrichment of 131 genes in-
volved in sensory perception, signal transduction and
cellular components (Additional file 6). The highest P-
values could be observed for the classifications olfaction
(P = 4.20x10-142), olfactory receptor (P = 2.40x10-134) and
sensory perception of smell (P = 6.90x10-132). Further ana-
lyses with the PANTHER classification system revealed
statistically over- and underrepresented biological pro-
cesses and confirmed the overrepresentation of genes in-
volved in sensory perception (P = 4.53x10-01) and signal
transduction as well as response to stimuli (Table 6). Pro-
cesses involved in cell cycle, transcription and metabolism
were underrepresented.
Analysis of the molecular functions demonstrated sig-
nificantly overrepresented processes concerning receptor
activities and particularly underrepresented catalytic and
hydrolase activities (Additional file 7). The PANTHER
protein class analysis showed a comparatively reduced
number of nucleic acid binding, transferase and hydro-
lase proteins. Our results suggest that CNV regions are
not randomly distributed among the genes of the horse
genome, but they harbour certain genes overrepresented
in those regions while other genes involved in specific
biological processes are underrepresented. Similar distri-
butions were observed in cattle and in CGH array ana-
lyses of 16 horses, showing sensory perception andsignal transduction to be the primary processes affected
by CNVs [5,7].
Furthermore, an enrichment of genes involved in
metabolic processes was also observed in CGH analyses
of horses [5]. Our study revealed an impoverishment of
CNVs in regions of genes responsible for a metabolic
process. This term is defined by PANTHER as chemical
reactions and pathways by which living organisms trans-
form chemical substances. A closer look at our analysis
of metabolic pathways shows that primary metabolic
processes, protein metabolic processes, nucleobase, nu-
cleoside, nucleotide and nucleic acid metabolic processes
were underrepresented while the cyclic nucleotide meta-
bolic process was overrepresented. We assume that meta-
bolic process is a very general term and has to be
interpreted in context of more specific ontology terms for
metabolic processes. Furthermore, we suppose that the
high number of horses used in our study in comparison
with previous CGH analysis might give a more general
view on the distribution of enriched and impoverished
genes in CNV regions. Similar to our results, human CNV
studies revealed a significant underrepresentation of genes
involved in nucleic acid metabolism in deletion regions
[29]. Furthermore, enriched gene categories concerning
sensory perceptions of smell, chemical stimuli, smell and
taste as well as neurophysiological processes, brain devel-
opment, immune responses and external biotic stimuli
could be shown in human [3,30,31]. It was assumed
that the underrepresentation of genes occurs due to
the strong selective pressure for genes involved in im-
portant processes like transcriptional regulation and
development [32].
Association analysis with body size
GWAS for body size was performed for each algorithm
on basis of its CNV detection results and for the inter-
section of all three detection programs. A highly
genome-wide significant peak on ECA1 could be shown
for the data generated by PennCNV (P = 0.006) and
QuantiSNP (P = 0.010). Analysis of the intersection of 50
CNVs revealed a P-value at the threshold of significance
(P = 0.057) presumably influenced by CNVPartition
which did not reveal any significant association. The as-
sociated CNVs were deletions in the region of 156 Mb
(Table 7). They were located in the area of the candidate
genes olfactory receptor 4, subfamily K5 (OR4K5),
subfamily K2 (OR4K2), subfamily N2 (OR4N2) and
subfamily M1 (OR4M1). GWAS for copy number
variation in human revealed the syntenic region of
40.25-40.39 Mb to be significantly associated with
stature [20]. It was proposed that individuals with short
stature show an excess of lower-frequency deletions
[20]. Our analysis revealed the heterozygous deletions
on ECA1 to be associated with larger sized horses.
Table 7 Genome-wide associated CNVs for body size in horses


















1 156,012,982 156,870,455 0.006 (0.001) 1 111
1 156,657882 156,870,455 0.010 (0.003) 1 80
1 156,657,882 156,818,876 0.057 (0.018) 1 132
8 4,430,473 4,430,473 0.001 (0.001) 0.081 (0.023) 1 12/61
8 4,579,478 4,621,044 0.0002 (0.0002) 1 33
9 29,889,627 29,892,897 0.006 (0.001) 0, 1 37
The chromosome-wide (EMP1; in brackets) and genome-wide corrected significant P-values (EMP2) of the associated CNV regions detected by PLINK for the
different algorithms and the number of animals showing a CNV in this region are given. For the intersection of three detection programs the P-value at the
threshold of significance is displayed. CNVPartition did not show any significant association.
Table 6 Gene ontology analysis of significantly over- and underrepresented genes
Number of reference
genes (Homo sapiens)





p-value for multiple testing
Biological process-overrepresented genes
Response to stress 586 17 3.60 1.34E-07 2.28E-05
G-protein coupled receptor protein
signaling pathway
1042 22 6.41 3.99E-07 6.82E-05
Muscle contraction 613 17 3.77 2.50E-07 4.28E-05
Sensory perception 864 13 5.31 2.65E-03 4.53E-01
Phagocytosis 101 6 0.62 4.25E-05 7.28E-03
Macrophage activation 352 8 2.16 1.58E-03 2.71E-01
Response to stimulus 1921 22 11.81 3.19E-03 5.46E-01
Cyclic nucleotide metabolic process 109 6 0.67 6.46E-05 1.10E-02
Nerve-nerve synaptic transmission 122 7 0.75 1.20E-05 2.06E-03
Synaptic transmission 756 12 4.65 2.51E-03 4.30E-01
Biological process-underrepresented genes
Cell cycle 1867 3 11.48 2.47E-03 4.22E-01
Transcription from RNA polymerase II
promoter
2343 2 14.41 3.30E-05 5.64E-03
Regulation of transcription from RNA
polymerase II promoter
1780 1 10.95 1.37E-04 2.33E-02
Transcription 2353 2 14.47 3.11E-05 5.31E-03
Primary metabolic process 8037 16 49.43 3.67E-11 6.28E-09
Nucleobase, nucleoside, nucleotide and
nucleic acid metabolic process
3987 8 24.52 2.75E-05 4.70E-03
Cellular component organization 1496 2 9.20 4.22E-03 7.21E-01
Mesoderm development 1621 2 9.97 2.14E-03 3.67E-01
Proteolysis 1230 1 7.56 3.69E-03 6.30E-01
Metabolic process 8351 17 51.36 1.78E-11 3.04E-09
Protein metabolic process 3295 3 20.26 6.38E-07 1.09E-04
The software PANTHER was used for the evaluation of 45 CNV regions detected by all three algorithms. In five CNV regions we could not detect any genes
for evaluation.
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body size (P = 0.0002), was located on ECA8 at 4.43-
4.62 Mb. All these heterozygous deletions could be
found in larger sized horses and were absent in smaller
horse breeds. The peak region harboured the candidate
genes immunoglobulin lambda variable 3–19 (IGLV3-19),
variable 3–27 (IGLV3-27) and variable 2–11 (IGLV2-11)
which all belong to the immunoglobulin lambda light
chain variable gene cluster, which is important for im-
munoglobulin structure [33].
A third candidate region could be detected by
QuantiSNP on ECA9 (P = 0.006) at 29.89 Mb. This CNV
showed deletions for 37 larger sized warmblood horses.
The neighbouring candidate genes opioid receptor, kappa
1 (OPRK1) and ATPase, H + transporting, lysosomal,
50/57-KD, V1 subunit H (ATP6V1H) have been shown
to be associated with body conformation in pigs [34].
Vacular-type H + ATPase proton pump is a complex
located in the ruffled border plasma membrane of
bone-resorbing osteoclasts and is important for bone
resorption. Mutations or deletions in V-ATPase subunits
encoding genes have been shown to decrease resorptive
activity in bones [35-37]. Further candidate genes in
the region of the associated CNV are the v-yes-1
yamaguchi sarcoma viral related oncogene homolog
(LYN), the trimethylguanosine synthase, S. cervisae,
homolog of (TGS1) and the pleiomorphic adenoma
gene 1 (PLAG1). Genome scans for sequence variants in
human revealed these genes to be in the region of SNPs
with the strongest correlation for height in a meta-analysis
[38]. The candidate gene PLAG1 is known to be involved
in developmental processes [39,40]. Its influence on bo-
vine stature could be shown by variants modulating the
expression of a chromosome domain encompassing
PLAG1 [39]. A targeted disruption of PLAG1 in mice
caused early growth retardation which was maintained
throughout adult life [40].
Our results showed that body size in horses is mainly
associated with homozygous or heterozygous deleted
CNVs on ECA1, ECA8 and ECA9. These regions do not
correspond with the region of the potential main regula-
tor LCORL or further associated SNPs or CNVs for body
size in horses [5,21-23]. We assume that the associated
CNVs detected in our analysis might represent add-
itional regulators in the complex process for the deter-
mination of height.
The association of the CNV regions on ECA1 and ECA8
could be confirmed by two detection algorithms, while the
peak region on ECA9 was exclusively detected by
QuantiSNP. The Illumina-based algorithm CNVPartition
did not reveal any association for body size although the
associated CNVs on ECA1 and ECA8 could be detected by
all three programs. We assume that the generally low
number of detected CNVs in only few horses were thereason for the missing association. For this reason we
propose that CNVPartition did not allow an appropriate
association analysis due to the high false negative rates.
This correlates well with our analysis for the detection ac-
curacy of each algorithm. The results demonstrate certain
limitations that have to be considered for the use of mul-
tiple predictions. It was proposed that analyses of different
detection algorithms have to be taken with care due to
false negative events but are also useful to avoid false posi-
tives caused by noisy data and call attention to discrepan-
cies in the data [11,15]. PennCNV and QuantiSNP were
shown to be more reliable in detecting CNVs than
CNVPartition [26]. Our analysis confirmed this suggestion
and showed that not only the number of compared CNV
detection events but also the choice of the program is im-
portant for an effective analysis.
qPCR validation
For validation of detected CNVs we performed qPCR
analysis in two CNVs on ECA1 and one CNV on ECA8
for twenty horses each (Additional file 8). We chose
three CNV regions that were detected by all three pro-
grams of which two were associated with body size
and one was also validated in horses of previous ana-
lysis [5]. All three CNV regions could be confirmed
by qPCR (Figure 3). The rate for the accurate copy
number detection of at least one algorithm was 95%
for Olfr1284 (ENSECAG00000006791) on ECA1 and
80% for IGLV3-32 (ENSECAG00000005113) on ECA8.
For the CNV region on ECA1 at the candidate gene
OR4K2 (ENSECAG00000006318) all horses could be
validated. The results show that the analysed CNVs
could be validated although few horses did not show the
copy number detected by SNP chip analysis. Similar ana-
lyses in pigs revealed accurate discovery rates of 71% [6].
Considering the individual programs, the false negative
discovery rate of CNVPartition was particularly high,
while QuantiSNP showed the lowest false negative discov-
ery rates in all three CNV regions (Additional file 9). We
assume that these results underline our comparative ana-
lyses for the detection algorithms showing QuantiSNP to
be the most reliable and accurate program.
In addition to this validation, we compared CNVs of
previous CGH analyses that were validated by qPCR
with our detection results. On the whole, four previously
verified CNVs could be confirmed in our analysis. One
of these CNVs was rare in our population and could
only be detected by QuantiSNP and CNVPartition, fur-
ther three CNVs could be found in a considerably higher
number of horses by QuantiSNP and also by PennCNV
in contrast to CNVPartition (Additional file 10). This
comparison helps to verify our CNV detection results in
these regions and confirms the assumption that there
are significant differences in the detection abilities of the
Figure 3 (See legend on next page.)
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Figure 3 Verification of detected CNVs by qPCR. The horizontal line represents the relative quantification level 1. Two copies are shown by
squares, one copy by triangles, zero copies by circles and three copies by rhombus. (A) The CNV region on ECA1 at 155.63 Mb was validated in
nineteen horses (solid symbols). One horse showed a homozygous deletion instead of two copies (unfilled symbol). (B) The CNV region on ECA1
at 156.69 Mb was validated in all twenty horses (solid symbols). (C) The CNV region on ECA8 at 4.50 Mb was validated in sixteen horses (solid
symbols). Four horses showed different copies as detected by SNP chip analysis (unfilled symbols).
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detected CNVs is crucial especially for further analyses
of associated regions, and helps to evaluate the accuracy
of the detection results by specific programs.
Conclusions
The aim of our analysis was to investigate three dif-
ferent algorithms for the detection of CNVs in
horses and to find associated CNVs for the regula-
tion of body size. Comparative analysis of the detec-
tion programs in 717 horses revealed 50 CNVs with
an average size of 388,892 bp. Functional analysis of
genes located in these CNVs confirmed the high
amount of OR genes (66.7%) and showed an over-
representation of genes involved in sensory percep-
tion, signal transduction and cellular components
while cell cycle, transcription and metabolic processes
were underrepresented.
We conclude that in general the creation of an inter-
section of three CNV-programs is useful to increase the
accuracy of CNV detection and to reduce the number
of false positive results. Nevertheless, the comparison
between these programs also provides a strong re-
striction and a higher number of false negative results
which is highly dependent on the choice of the detec-
tion tool. We recommend taking advantage of the dif-
ferent algorithms used in detection programs and to
perform multiple predictions in a first step. Such an
analysis will show possible limitations and establish
suitable algorithms for further evaluations. In our
study the combined use of PennCNV and QuantiSNP
was most effective for the accurate detection of
CNVs. GWAS for the CNV detection results of these
algorithms identified for body size three homozygous
or heterozygous deleted CNV regions associated with
larger sized horses on ECA1, ECA8 and ECA9. Two
of these regions were analysed by qPCR and could be
validated. We conclude that a comparative CNV ana-
lysis is a useful approach as it reveals the limitations
of individual programs and helps to estimate the reli-
ability of the detection results.
Methods
Ethic statement
All animal work has been conducted according to
the national and international guidelines for animal
welfare. The sampling was approved by the LowerSaxony state veterinary office Niedersächsisches Landesamt
für Verbraucherschutz und Lebensmittelsicherheit,
Oldenburg, Germany (registration numbers 509c-42502-
01A60, 02A-138 and 07A-482).
Sample preparation
EDTA-blood samples of 17 different breeds were col-
lected including 148 Arabian, one Anglo-Arabian, two
Brandenburger, 514 Hanoverian, nine Holsteiner, 13
Oldenburg, five Trakehner, 35 Westphalian, one Selle
Francais, one German Riding Pony, 47 Lusitano, 48
Maremanno, two Przewalski, 12 Rhinelander horse,
two Rhenish-German Cold-Blood, 14 Thoroughbred
and one Zweibrücker. The horses were chosen out of
different breeding lines to provide unrelated horses as
far as possible. For genotyping we isolated genomic
DNA using standard methods with RBC (Red Blood
Cell) lysis buffer and SE (sodium EDTA) buffer. The DNA
concentration of the samples was adjusted to 50 ng/μl
using the Nanodrop ND-1000 (Peqlab Biotechnology,
Erlangen, Germany) and quality control was performed by
gel electrophoresis using 1% agarose gels (peqGold
Universal Agarose, Peqlab Biotechnologie, Erlangen,
Germany). All 854 animals were genotyped using the
Illumina equine SNP50 BeadChip (Illumina, San
Diego, USA) including 54,602 SNPs.
Data analysis
To provide reliable results, quality control was performed
in a first step by the choice of DNA samples with high
qualities and the determination of a call rate >90% for ani-
mals and SNPs. Further criteria for the exclusion of noisy
data were chosen individually for each algorithm. Primary
visualisation and quality control of the CNV data was
performed with the GenomeStudio software (Illumina).
Data files containing SNP name, chromosome, position,
B-allele frequency and log R ratio were exported as a
unique file and separated using the split option in
PennCNV package. Analysis of the autosomal regions for
CNV was done in three different programs. PennCNV
was run according to default criteria (Illumina) [17] using
the command line detect_cnv.pl –hmm example.hmm –
pfb horse909Tiere.pfb –minsnp 3 –lastchr 31 –test –
tabout –coord –conf –listfile list.txt –out penncnv1.txt
and probe counts less than three were omitted afterwards.
Quality control was performed employing standard
exclusions of the Log Ratio (SD (LRR)) >0.3 and the
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(│GCWF│) >0.02. An individual-call mode was used
for all samples. Then we used QuantiSNP 2.0, a pro-
gram based on an Objective Bayes Hidden-Markov
Model (HMM) [24], for CNV analysis. The detection
was performed by the command: quantisnp2 –outdir
horse –logfile 909Pferde –chr [1:31] –chrx 32 –
beadstudio-files 909Pferde.txt. After CNV detection
the minimum probe count of three, a threshold for
the Log Bayes Factor of less than ten was set. The
GenomeStudio plug-in cnvPartition 3.1.6 was run by
default criteria including a confidence threshold of 35,
a minimum homozygous region size of 1,000,000 a
minimum probe count of 3 and GcWaveAdjustLRR.
GWAS for the CNV detection results of each indi-
vidual programme and the intersection of PennCNV,
QuantiSNP and cnvPartition was performed using
PLINK version 1.07 (http://pngu.mgh.harvard.edu/pur-
cell/plink/) [41] and SAS/Genetics, version 9.3 (2013)
in a quantitative trait analysis. A mixed linear model
(MLM) was employed to control data for stratifica-
tion. Size ranges for every breed were estimated and
results were averaged as it was shown in our previous ana-
lysis for body size (Table 4) [23]. The chromosomal en-
richment was also accounted with SAS/Genetics for each
algorithm similar to the enrichment analysis in the
CGH study [5] by merging overlapping CNVs on
basis of the SNP map of 48860 SNPs to CNV regions.
The number of SNPs covered by CNV regions was
divided by the length of the chromosome. The whole-
genome coverage of CNV regions was used as stand-
ard after dividing by the total length of the autosomes.
Significant chromosomal enrichment occurred when the
enrichment of the genome was lower than the enrichment
of the chromosome.
Ontology analysis
Genes located in the CNV regions of the intersection
of all three programs were identified using NCBI
MapViewer http://ftp.ncbi.nih.gov/genomes/MapView/
Equus_caballus. Due to the insufficient annotation of the
horse genome, we determined the human orthologs for
these genes by NCBI gene http://www.ncbi.nlm.nih.gov/
gene and HomoloGene http://www.ncbi.nlm.nih.gov/
homologene to perform ontology analysis. The Database
for Annotation, Visualization and Integrated Discovery
(DAVID) 6.7 (http://david.abcc.ncifcrf.gov/home.jsp) was
used for functional annotation of genes in CNV re-
gions [42,43]. The functional annotation chart was
run with a count threshold of 2, an EASE Score
threshold of 0.1 and the Bonferoni correction. Results
were grouped in functional groups. Further ontology ana-
lysis was performed using the PANTHER (Protein
ANalysis THrough Evolutionary Relationships, version8.0) classification system http://www.pantherdb.org/
for the classification of genes by their molecular func-
tion, biological process and cellular component with
default Bonferoni correction [44].
qPCR validation
Validation of three different genomic regions harbouring
CNVs was performed by quantitative real-time (qRT)-
PCR on the ABI7300 sequence detection system (Applied
Biosystems by Life Technologies, Darmstadt, Germany).
On the whole eighteen warmblood horses and two
Arabians were analysed. DNA was isolated from blood
samples in the same way as it was done for SNP chip
analysis. The DNA concentration of the samples was ad-
justed to 10 ng/μl using the Nanodrop ND-1000 (Peqlab
Biotechnology).
Primer pairs and probes were designed using Primer
express 3.0 (Applied Biosystems) and Primer3 (http://
frodo.wi.mit.edu/primer3/). Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) on ECA6 was used as reference
gene according to previous CNV analyses in horses [5].
Reactions were assembled in a final volume of 12 μl
containing 2.0 μl gDNA, 1.0 μl reverse and 1.0 μl
forward primes (10 pmol; Additional file 6), 0.25 μl VIC-
labeled TaqMan probe for CNV regions (6 nmol;
100 μM) and FAM-labeled TaqMan probe for GAPDH,
1.68 μl nuclease free water and 6 μl Maxima Probe
qPCR master mix 2x supplemented by 0.07 μl ROX
Solution (50 μM; Fermentas Life Sciences, St. Leon-Rot,
Germany). Quantitative real-time (qRT)-PCR was
performed for 10 minutes (min) at 95°C followed by
40 cycles at 95°C for 15 seconds and 60°C for 1 min.
Analysis was done for every sample two times and the
average value was used for further calculations. One
sample without copy number variations in the analysed
regions was used as reference. For the relative quanti-
fication of CNVs we used the 2-ΔΔCt method [45].
The ΔCT values of the test samples were subtracted
from the ΔCT of the reference sample and put in the
formula 2-ΔΔCt.Additional files
Additional file 1: CNVs detected by CNVPartition. The table
summarises start and end positions of detected CNVs, their size, copy
number, number of samples and genes located in CNV regions. Text in
PDF format.
Additional file 2: CNVs detected by PennCNV. The table summarises
start and end positions of detected CNVs, their size, copy number, number
of samples and genes located in CNV regions. Text in PDF format.
Additional file 3: CNVs detected by QuantiSNP. The table summarises
start and end positions of detected CNVs, their size, copy number, number
of samples and genes located in CNV regions. Text in PDF format.
Additional file 4: Comparative analysis of three CNV detection
algorithms. The table shows 50 CNVs derived from three detection
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(HAN: Hanoverian; LUS: Lusitano; MAR: Maremanno; OLD: Oldenburg;
RDK: Rhenish-German Cold-Blood; WES: Westphalian; HOL: Holsteiner;
TB-H: Thoroughbred; AV: Arabian; RHD: Rhinelander horse; PRZ:
Przewalski; BRAN: Brandenburger; TRAK: Trakehner; RPON: German Riding
Pony). Text in PDF format.
Additional file 5: Display of CNVs detected in two Przewalski
horses by comparative analysis of three algorithms. The overlap of
CNVs with different breeds is shown.
Additional file 6: Functional annotation analysis of enriched genes
derived from 45 CNV regions using DAVID 6.7. In five CNV regions
we could not detect any genes for evaluation. Text in DOC format.
Additional file 7: Gene ontology analysis of significantly over- and
underrepresented genes involved in molecular functions and
protein classes. The software PANTHER was used for the evaluation of
45 CNV regions detected by all three algorithms.
Additional file 8: Genomic regions analysed for copy number
variants (CNVs) by real-time quantitative RT-qPCR. Primer sequences,
their position, product size, annealing temperature and TaqMan probes
are shown. Text in DOC format.
Additional file 9: Copy number detection accuracy of three SNP
array algorithms. The deleted (0, 1) or duplicated (3) copy numbers
validated by qPCR are compared with the detection results of
CNVPartition, PennCNV and QuantiSNP. Reference samples with the copy
number 2 are not displayed as they were selected specifically for two
copies in all three programs.
Additional file 10: Comparison of CNVs validated by qPCR in CGH
analysis (Doan et al.) with CNVs detected by CNVPartition, PennCNV
and QuantiSNP. The number of samples detected by QuantiSNP is
considerably high.
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